Full Press Release Details
regeneron advances allergy pipeline with two positive phase 3 trials evaluating first in class antibody blockers of cat and birch allergies.
REGN
regeneron advances allergy pipeline with two positive phase 3 trials evaluating first in class antibody blockers of cat and birch allergies
Key Takeaway: regeneron advances allergy pipeline with two positive phase 3 trials evaluating first in class antibody blockers of cat and birch allergies